Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases
This paper introduces a class of time-scale target parameters to quantify treatment effects as time saved or percentage slowing of progression in longitudinal trials for progressive diseases, proposing a general two-step estimation framework implemented in the TCT R package that facilitates interpretation and evaluation of treatment efficacy, as demonstrated in an Alzheimer's disease clinical trial.